Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL(+) leukemia stem cells (Articolo in rivista)

Type
Label
  • Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL(+) leukemia stem cells (Articolo in rivista) (literal)
Anno
  • 2010-01-01T00:00:00+01:00 (literal)
Alternative label
  • Palamà I.E., Leporatti S., de Luca E., Di Renzo N., Maffia M., Gambacorti-Passerini C., Rinaldi R., Gigli G., Cingolani R. and Coluccia A.M.L. (2010)
    Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL(+) leukemia stem cells
    in Nanomedicine (Lond., Print)
    (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
  • Palamà I.E., Leporatti S., de Luca E., Di Renzo N., Maffia M., Gambacorti-Passerini C., Rinaldi R., Gigli G., Cingolani R. and Coluccia A.M.L. (literal)
Rivista
Note
  • ISI Web of Science (WOS) (literal)
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
  • 1. Univ Salento, Scuola Super ISUFI, CNR, INFM,IIT Res Unit,Natl Nanotechnol Lab, I-73100 Lecce, Italy (Palamà I.E., Leporatti S., Rinaldi R., Gigli G., Cingolani R. and Coluccia A.M.L.) 2. Vito Fazzi Hosp, Lecce, Italy 3. Univ Milano Bicocca, Milan, Italy (literal)
Titolo
  • Imatinib-loaded polyelectrolyte microcapsules for sustained targeting of BCR-ABL(+) leukemia stem cells (literal)
Abstract
  • m: The lack of sensitivity of chronic myeloid leukemia (CML) stem cells to imatinib mesylate (IM) commonly leads to drug dose escalation or early disease relapses when therapy is stopped. Here, we report that packaging of IM into a biodegradable carrier based on polyelectrolyte microcapsules increases drug retention and antitumor activity in CML stem cells, also improving the ex vivo purging of malignant progenitors from patient autografts. Materials & methods: Microparticles/capsules were obtained by layer-by-layer (LbL) self-assembly of oppositely charged polyelectrolyte multilayers on removable calcium carbonate (CaCO3) templates and loaded with or without IM. A leukemic cell line (KU812) and CD34(+) cells freshly isolated from healthy donors or CML patients were tested. Results & discussion: Polyelectrolyte microcapsules (PMCs) with an average diameter of 3 pm, fluorescently labelled multilayers sensitive to the action of intracellular proteases and 95-99% encapsulation efficiency of IM, were prepared. Cell uptake efficiency of such biodegradable carriers was quantified in KU812, leukemic and normal CD34(+) stem cells (range: 70-85%), and empty PMCs did not impact cell viability. IM-loaded PMCs selectively targeted CML cells, by promoting apoptosis at doses that exert only cytostatic effects by IM alone. More importantly, residual CML cells from patient leukapheresis products were reduced or eliminated more efficiently by using IM-loaded PMCs compared with freely soluble IM, with a purging efficiency of several logs. No adverse effects on normal CD34(+) stem-cell survival and their clonogenic potential was noticed in long-term cultures of hematopoietic progenitors in vitro. Conclusion: This pilot study provides the proof-of-principle for the clinical application of biodegradable IM-loaded PMC as feasible, safe and effective ex vivo purging agents to target CML stem cells, in order to improve transplant outcome of resistant/relapsed patients or reduce IM dose escalation. (literal)
Prodotto di
Autore CNR

Incoming links:


Autore CNR di
Prodotto
Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
data.CNR.it